Physician profile
Pedro P Maria
NPI 1740394618
$241,931.36
in general payments reported to CMS, 2019-2025
37 companies · $52K in 2025
The $52K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $8,984 · 2021: $21K · 2022: $7,238 · 2023: $53K · 2024: $61K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $123K · Travel and Lodging: $22K · Food and Beverage: $21K · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $122,942.27 |
| Travel and Lodging | $21,716.34 |
| Food and Beverage | $21,065.88 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $210,861.06 | 2019-2025 | Titan, Virtue, Coloplast Tfl Drive |
| Axogen | $9,081.48 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Davol INC. | $5,902.83 | 2020-2024 | Arista Ah Flexitip, Phasix Mesh |
| Kerecis Limited | $3,240.70 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Neotract INC. | $2,254.24 | 2019-2020 | |
| Boston Scientific Corporation | $1,819.20 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Spaceoar Vue System - 10ml |
| Teleflex LLC | $1,150.14 | 2021-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $958.56 | 2020-2024 | Xiaflex, Edex, Aveed |
| Astellas Pharma US INC | $799.94 | 2019-2024 | Veozah, Myrbetriq |
| Becton, Dickinson and Company | $684.43 | 2025 | Arista, Avitene Ultrafoam |
| Ethicon US, LLC | $669.63 | 2019-2025 | Echelon Flex |
| Palette Life Sciences, INC. | $550.72 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $483.78 | 2023-2025 | Gemtesa, Orgovyx |
| Calyxo, INC. | $401.36 | 2024-2025 | Cvac Aspiration System |
| Endo USA, INC. | $300.65 | 2024-2025 | Xiaflex, Aveed, Edex |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $297.65 | 2023 | Aquabeam Robotic System |
| Progenics Pharmaceuticals, INC. | $282.22 | 2023-2024 | Pylarify |
| Rigicon,INC. | $264.83 | 2022-2024 | Rigi10 Malleable Penile Prosthesis, Rigi10 Malleable Penile Prosthesis |
| Axonics, INC. | $248.70 | 2021-2023 | Axonics |
| Novartis Pharmaceuticals Corporation | $233.11 | 2019 | |
| Pfizer INC. | $231.54 | 2020-2021 | |
| Medtronic, INC. | $203.90 | 2024 | Signia |
| Urogen Pharma, INC. | $175.16 | 2022 | |
| Karl Storz Lithotripsy-America | $150.00 | 2022 | |
| Contura, INC. | $139.96 | 2020 | |
| Angiodynamics, INC. | $132.23 | 2022 | |
| Ambu INC. | $89.31 | 2020-2021 | |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Laborie Medical Technologies Corp. | $45.46 | 2020 | |
| Dendreon Pharmaceuticals LLC | $44.66 | 2025 | Provenge |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Myriad Genetic Laboratories, INC. | $34.66 | 2022 | |
| Acerus Pharmaceuticals Corporation | $33.74 | 2022 | |
| Janssen Biotech, INC. | $24.98 | 2025 | Erleada |
| Avanos Medical | $24.41 | 2022 | |
| Intuitive Surgical, INC. | $17.09 | 2021 | |
| Tolmar, INC. | $13.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Maria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.